Helen Ambizas, O.D.
Optometrist in Stratford, Connecticut.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 60,463 in Optometrist, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Source: CMS Medicare Part D Prescriber Public Use File, 2023
What the federal data shows
Helen Ambizas, O.D. filed 441 Medicare Part D claims in 2023 as a Optometrist in Stratford, Connecticut, prescribing 22% generic.
- 441
- Part D claims, 2023
- 22%
- generic prescribing
- $644.59
- industry payments (Sunshine Act)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Helen Ambizas, O.D.'s Medicare Part D volume vs every U.S. prescriber
Total Medicare Part D claims, 2023, across all CMS prescribers nationally
441 Top 38% higher than 62% of 1,370,886 prescribers
Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source CMS Medicare Part D Prescriber Public Use File · 2023
What does the federal data show about Helen Ambizas, O.D.?
Quality data not reportedPrimary specialty
Medicare Part D claims
Specialty distribution in Connecticut
How Optometrist compares to other specialties among Connecticut providers
Optometrist ranks #35 among Connecticut's specialties (0.8% of in-state providers)
Each bar is a specialty's share of the Connecticut provider total, by primary NUCC taxonomy. The highlighted bar is Optometrist; the long tail of smaller specialties is omitted for legibility.
Board certification
Not published by CMS
CMS does not publish a per-provider board-certification field in NPPES. PlainDoctor does not have a reliable per-specialty certification rate to show for Optometrist. Verify directly:
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Helen Ambizas, O.D. appears in the CMS NPPES registry as a Optometrist provider holding O.D. credentials at 775 MAIN ST, Stratford, CT, 06615, with a listed phone of (203) 377-2020. NPI 1376716860 was issued on 04/07/2008.
Medicare Part D records for calendar year 2023 show 441 prescription claims written by this provider, covering 143 Medicare beneficiaries and totaling roughly $379K in drug spend, split 78% brand-name and 22% generic by claim count.
Optometrist is a high-volume specialty nationwide, with 60,463 enrolled providers across 56 states and an average of 257 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline.
Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist, always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1376716860 |
|---|---|
| Specialty | Optometrist |
| Credentials | O.D. |
| Gender | Female |
| NPI Issued | 04/07/2008 |
Verify this provider's license
PlainDoctor pulls this profile from the CMS NPPES public registry. Confirm Helen Ambizas, O.D.'s current license status, disciplinary history, and board certifications with the Connecticut Department of Public Health in Connecticut before relying on this page for a clinical or care decision.
How we sourced this profile
Profile fields combine the CMS NPPES monthly snapshot (provider directory, taxonomy, and address) with calendar-year 2023 Medicare Part D and MIPS public-use files when records are present. NPI 1376716860 is the unique 10-digit identifier CMS uses to link Ambizas across every Medicare, Medicaid, and HIPAA-covered transaction. Read full methodology →
Hospital and facility affiliations
Facilities where Helen Ambizas, O.D. bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" - a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.
Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).
Industry payments received (2024) - CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Helen Ambizas, O.D.. Source: openpaymentsdata.cms.gov.
Total received
$645
Largest payer
Tarsus Pharmaceuticals, Inc.
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
Brand vs generic prescribing mix · Brand-heavy
78% brand-name claims vs 22% generic, on 441 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
Prescribing Breakdown
- 30-Day Fills
- 843
- Total Day Supply
- 24,660
- Brand vs Generic
- 78% brand / 22% generic
- Brand Drug Cost
- $371K
- Generic Drug Cost
- $8K
Patient Demographics
- Average Patient Age
- 66.7 years
- Avg HCC Risk Score
- 1.35
- Gender Split
- 75% female / 25% male
- Age Distribution
- <65: 45, 65-74: 73, 75-84: N/A, 85+: N/A
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What Helen Ambizas, O.D. prescribes most
Top Medicare Part D drugs by claim count, 2023
- Xiidra
Xiidra
118 claims
- Restasis
Restasis
115 claims
- Latanoprost
Latanoprost
74 claims
- Loteprednol Etabon… 16
Loteprednol Etabonate
16 claims
- Lumigan 15
Lumigan
15 claims
- Alrex 12
Alrex
12 claims
- Travoprost 11
Travoprost
11 claims
| Drug | Claims |
|---|---|
| Xiidra Lifitegrast | 118 |
| Restasis Cyclosporine | 115 |
| Latanoprost | 74 |
| Loteprednol Etabonate | 16 |
| Lumigan Bimatoprost | 15 |
| Alrex Loteprednol Etabonate | 12 |
| Travoprost | 11 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Optometrist Overview
How Helen Ambizas, O.D. fits within the Optometrist landscape nationally.
Helen Ambizas, O.D.'s 441 claims are above the specialty average of 257.
Nearby Optometrist Providers in Connecticut
Other clinicians with the same primary specialty enrolled in Connecticut, drawn from the same CMS NPPES roster as Ambizas.
Compare Optometrist nationally: see state-by-state distribution →
Before you book an appointment
Use this federal record as your verification checklist, not as a recommendation.
- Confirm the NPI record is current in the official CMS registry, providers update their own NPPES details, and moves can lag. Verify this NPI
- Check the active license and any disciplinary history with the Connecticut medical board, federal registration is not a license check. Credential verification guide
- Weigh a second option: compare this provider with a nearby Optometrist peer on Medicare volume and prescribing patterns. Compare providers
Medicare Part D and MIPS figures describe practice patterns in federal programs only, they are not quality ratings, and PlainDoctor does not rate, rank, or recommend providers.
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
Explore Connecticut
Frequently Asked Questions
What is Helen Ambizas, O.D.'s specialty? ▼
How much does Helen Ambizas, O.D. prescribe under Medicare Part D? ▼
Where is Helen Ambizas, O.D. located? ▼
What is Helen Ambizas, O.D.'s NPI number? ▼
Does Helen Ambizas, O.D. prescribe more brand-name or generic drugs? ▼
How many Optometrist providers are there in the US? ▼
What drugs does Helen Ambizas, O.D. prescribe most often? ▼
Does Helen Ambizas, O.D. accept Medicare? ▼
How can I verify Helen Ambizas, O.D.'s credentials? ▼
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology